1-20 of 97
Sort by
News

Study Characterizes Mutational Pattern of Non-Immune Hemolytic Anemia in MDS

Published: 2023
Abstract
February 2023
View News
News

Phase I/II Study Results in 87% Overall Response Rate With Venetoclax, Azacitidine Combo in High-Risk MDS

Published: 2022
Abstract
December 2022
View News
News

Luspatercept Improves Anemia After Five Years in Patients With Lower-Risk MDS

Published: 2022
Abstract
December 2022
View News
News

Model Helps Predict Use of Single-Agent Romiplostim in Lower-Risk MDS

Published: 2022
Abstract
December 2022
View News
News

Enasidenib Shows Durable Response in IDH2-Mutant MDS

Published: 2022
Abstract
Mid-November 2022
View News
News

Pathogenic Germline Variants Seen in Older Patients With MDS More Frequently Than Expected

Published: 2022
Abstract
November 2022
View News
News

Hydroxyurea Use Does Not Increase Risk of Secondary Malignancies with MPNs

Published: 2022
Abstract
November 2022
View News
News

CMS Expands Coverage for Hematopoietic Cell Transplantation: Proceed with Cautious Optimism

Published: 2021
View News
News

Should Patients With Myelodysplastic Syndromes Undergo Transplant?

Published: 2021
View News
News

Could Adding Sotatercept to Ruxolitinib Improve MPN-Associated MF and Anemia?

Published: 2021
View News
News

Single-Agent Vadastuximab Talirine Active, Tolerable in AML

Published: 2021
View News
News

Newly Approved Drugs for AML: How to Use Them in Practice

Published: 2021
View News
News

Momelotinib Trial in Myelofibrosis Fails to Meet Primary Endpoint

Published: 2021
View News
News

Early-Phase Study Finds Duvelisib Active in Variety of Advanced Hematologic Malignancies

Published: 2021
View News
News

Treating MRD With Azacitidine in Patients With High-Risk AML and MDS

Published: 2021
View News
News

Idasanutlin Well Tolerated in Patients With Polycythemia Vera and Essential Thrombocythemia

Published: 2021
View News
News

Preliminary Results Show Flotetuzumab Well-Tolerated and Effective in Relapsed/Refractory AML and MDS

Published: 2021
View News
News

Examining the Risk of Cardiovascular Disease–Related Mortality in Patients With and MDS/CMML

Published: 2021
View News
News

Mixed Results From SIMPLIFY-1 Complicate Myelofibrosis Treatment Decisions

Published: 2021
View News
News

Eltrombopag Reduces Thrombocytopenic Events in Patients With AML and MDS, But Not as Much as Expected

Published: 2021
View News